Oncolytics Biotech Inc.
ONCY
$0.80
-$0.01-1.24%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.44M | -9.24M | -8.88M | -10.46M | -5.28M |
| Total Depreciation and Amortization | 15.00K | 16.00K | -137.10K | 67.50K | 18.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.52M | 3.12M | 2.42M | 3.68M | 1.58M |
| Change in Net Operating Assets | -1.23M | -1.18M | 72.90K | 1.88M | -427.00K |
| Cash from Operations | -8.14M | -7.29M | -6.53M | -4.83M | -4.11M |
| Capital Expenditure | 0.00 | -6.00K | -900.00 | -5.10K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -6.00K | -900.00 | -5.10K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 223.20K | -101.00K | -- |
| Issuance of Common Stock | 6.52M | 7.86M | 2.52M | 4.43M | 3.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 247.00K | -247.00K | 145.30K | -194.00K | 144.00K |
| Cash from Financing | 6.77M | 7.61M | 2.89M | 3.00M | 4.09M |
| Foreign Exchange rate Adjustments | -11.00K | -24.00K | 386.50K | 178.60K | 88.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.38M | 291.00K | -3.26M | -1.65M | 76.00K |